Who are Biolattice Ophthalmics, Inc.'s investors?

Biolattice Ophthalmics, Inc.'s investors include Life Sciences Greenhouse Investments, Robin Hood Ventures.

How much funding has Biolattice Ophthalmics, Inc. raised?

Biolattice Ophthalmics, Inc. has disclosed $575K raised across 1 round.

Where is Biolattice Ophthalmics, Inc. headquartered?

Biolattice Ophthalmics, Inc. is headquartered in Philadelphia, US.

Biolattice Ophthalmics, Inc.

Philadelphia, US · Founded 2023 · Delaware corporation · 2 known investors

BioLattice develops engineered cornea tissue as an alternative to donor cornea for patients with corneal blindness and those waiting for transplants. The company focuses on tissue engineering to address the shortage of donor cornea supply in the global ophthalmology market.

Biotech Healthtech Medical Devices

Founders & leadership

Linda AlunkalExecutive

Amelia ZellanderinNamed on SEC filing

Board

Gregory JacksonBoard directorExecutive Vice President at Life Sciences Greenhouse Investments

Investors · 2

Life Sciences Greenhouse InvestmentsHarrisburg · $250K – $500K

Robin Hood VenturesPhiladelphia · $250K – $1Mvia Pitou Devgon · inferred

Reported raises · per SEC filings

Form D private placements

$575K disclosed across 1 round · 2026

▶$575KraisedMar 2026 · 2 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Gregory JacksonDirector
Amelia ZellanderExecutive Officer, Director
Linda AlunkalExecutive Officer, Director

Offering amount: $2.5M
Amount sold: $575K
First sale: Mar 2026
Incorporated: Corporation, Delaware, 2023
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap

Bioworld3 shared keywordsBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.

Companies competing with Biolattice Ophthalmics, Inc. for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Biolattice Ophthalmics, Inc. do?: BioLattice develops engineered cornea tissue as an alternative to donor cornea for patients with corneal blindness and those waiting for transplants. The company focuses on tissue engineering to address the shortage of donor cornea supply in the global ophthalmology market.
Who are Biolattice Ophthalmics, Inc.'s investors?: Biolattice Ophthalmics, Inc.'s investors include Life Sciences Greenhouse Investments, Robin Hood Ventures.
How much funding has Biolattice Ophthalmics, Inc. raised?: Biolattice Ophthalmics, Inc. has disclosed $575K raised across 1 round.
Where is Biolattice Ophthalmics, Inc. headquartered?: Biolattice Ophthalmics, Inc. is headquartered in Philadelphia, US.